Imiquimod to treat basal cell and squamous cell carcinomas.
Keller
Curtis D
CD
D000279:Administration, Cutaneous; D000634:Aminoquinolines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D000077271:Imiquimod; D018579:Patient Selection; D012878:Skin Neoplasms / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod